{
  "conversation_id": "b514664201ad62fb2374e0e2af3aa32722150c70076ba619e929ea31ca15af0d",
  "chat_history": "{\n  \"messages\": [\n    {\n      \"metadata\": {},\n      \"content_type\": \"message\",\n      \"role\": \"user\",\n      \"items\": [\n        {\n          \"metadata\": {},\n          \"content_type\": \"text\",\n          \"text\": \"Given the KRAS p.G12C mutation in patient_4, summarize current treatment options including KRAS inhibitors, chemo-immunotherapy, and emerging trial drugs. Include efficacy, risk profile, and how this may affect prognosis\"\n        }\n      ]\n    },\n    {\n      \"ai_model_id\": \"gpt-5\",\n      \"metadata\": {\n        \"logprobs\": null,\n        \"id\": \"chatcmpl-CBgG6B2jgOkeTuu1UbafntgAfM826\",\n        \"created\": 1756900086,\n        \"system_fingerprint\": null,\n        \"usage\": {\n          \"prompt_tokens\": 1261,\n          \"completion_tokens\": 1782\n        }\n      },\n      \"content_type\": \"message\",\n      \"role\": \"assistant\",\n      \"name\": \"Orchestrator\",\n      \"items\": [\n        {\n          \"metadata\": {},\n          \"content_type\": \"text\",\n          \"text\": \"Planned moderation steps:\\n- Clarify the objective and define which agents need to participate\\n- Validate and retrieve the patient\u2019s timeline/history using the provided patient ID\\n- Derive a concise current patient status to ground subsequent agents\\n- Coordinate guideline-based options, trial landscape, and supporting research evidence\\n- Collect any imaging or document needs; note gaps if inputs are unavailable\\n- Provide micro-updates after each agent and ensure each yields back control\\n- Summarize the collective output and ask for next steps\\n\\nProposed plan and participation order:\\n1) PatientHistory: Retrieve and summarize the timeline for patient_4 to anchor the discussion.\\n2) PatientStatus: Convert the history into a concise current status (age, primary site, histology, stage, biomarkers, ECOG, prior therapies).\\n3) ClinicalGuidelines: Summarize current option categories relevant to KRAS p.G12C (e.g., KRAS inhibitors, chemo-immunotherapy) including typical efficacy/risk profiles; no patient-specific recommendations.\\n4) ClinicalTrials: Outline emerging trial drugs and active trial directions that match the status of patient_4.\\n5) MedicalResearch: Provide recent evidence on efficacy, safety, resistance, and implications for prognosis in KRAS p.G12C.\\n6) Radiology: Note if any imaging is available; if none, state what would be needed for radiology insights.\\n7) ReportCreation: Compile a concise tumor board\u2013style document once upstream inputs are available.\\n\\nSpecial rule \u2014 agent handoff:\\nEach agent, after completing their task, must yield the chat back to me (the Orchestrator). Please conclude with: \u201cback to you: Orchestrator\u201d.\\n\\nUser, please confirm:\\n- Confirm that we should proceed with this plan for patient_4.\\n- If available, do you have any recent imaging (e.g., chest X-ray/CT) or pathology reports you want included?\\n- Any urgent topics you want emphasized (e.g., CNS disease, prior toxicities, comorbidities)?\\n\\nOn your confirmation, I will start by requesting the timeline from PatientHistory for patient_4.\"\n        }\n      ],\n      \"finish_reason\": \"stop\"\n    }\n  ]\n}",
  "patient_id": null,
  "patient_data": [],
  "display_blob_urls": [],
  "display_clinical_trials": [],
  "output_data": [],
  "healthcare_agents": {}
}